VEGFA and lung carcinoma: Taking all these data into consideration, it is proposed that Ang-2 might be an interesting target for future therapeutic approaches in lung cancer, while the therapeutic benefit of simultaneous blockade of Ang-2 and VEGF in lung cancer remains to be further clarified.